Campus address: 1161 Medical Laboratories

Primary department: Pathology

Interdisciplinary program(s): Human Toxicology

Research description: Dr. Burnett’s research focuses on the relationship between EGFR and AKT signal transduction pathways, energy metabolism and NADPH oxidase (NOX)-induced oxidative stress in cancer cells to develop highly targeted strategies to improve cancer patient treatment and outcomes. Her laboratory seeks to enhance the treatment of head and neck cancer by improving radiotherapy and chemotherapy regimens for recurrent and metastatic disease. They focus in particular on epidermal growth factor receptor (EGFR) signaling and the increasing use of EGFR inhibitors for the treatment of head and neck cancer.